Provided by Tiger Trade Technology Pte. Ltd.

bioAffinity Technologies, Inc.

9.29
+2.7040.90%
Volume:21.07M
Turnover:207.28M
Market Cap:5.50M
PE:-0.09
High:11.42
Open:7.64
Low:7.54
Close:6.59
52wk High:202.50
52wk Low:4.56
Shares:592.37K
Float Shares:586.87K
Volume Ratio:11.31
T/O Rate:3590.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-103.3536
EPS(LYR):-129.9452
ROE:-1860.15%
ROA:-125.11%
PB:1.46
PE(LYR):-0.07

Loading ...

Apr 04, 2024

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Apr 01, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 01, 2024

Major Issues Report

Form 8-K - Current report
Mar 13, 2024

Major Issues Report

Form 8-K - Current report
Mar 08, 2024

Major Issues Report

Form 8-K - Current report
Mar 05, 2024

Major Issues Report

Form 8-K - Current report
Jan 31, 2024

Major Issues Report

Form 8-K - Current report
Dec 05, 2023

Major Issues Report

Form 8-K - Current report
Nov 30, 2023

Major Issues Report

Form 8-K - Current report
Nov 22, 2023

Correspondence

Form CORRESP - Correspondence
Nov 15, 2023

Major Issues Report

Form 8-K - Current report
Nov 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 03, 2023

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 03, 2023

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Oct 18, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Oct 10, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Oct 10, 2023

Major Issues Report

Form 8-K - Current report
Sep 21, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Sep 21, 2023

Major Issues Report

Form 8-K - Current report
Aug 14, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]